Hematopoiesis and Cardiovascular Disease.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32271679.
- Also identified by DOI 10.1161/CIRCRESAHA.120.315895 and PMC identifier 7153537.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A central feature of atherosclerosis, the most prevalent chronic vascular disease and root cause of myocardial infarction and stroke, is leukocyte accumulation in the arterial wall. These crucial immune cells are produced in specialized niches in the bone marrow, where a complex cell network orchestrates their production and release. A growing body of clinical studies has documented a correlation between leukocyte numbers and cardiovascular disease risk. Understanding how leukocytes are produced and how they contribute to atherosclerosis and its complications is, therefore, critical to understanding and treating the disease. In this review, we focus on the key cells and products that regulate hematopoiesis under homeostatic conditions, during atherosclerosis and after myocardial infarction.
Medical subject headings
- Cardiovascular Diseases
- Endothelium, Vascular
- Hematopoiesis